Effectiveness of Mindfulness-Based Cognitive Therapy With Follow-Up Sessions for Pharmacotherapy-Refractory Anxiety Disorders: Protocol for a Feasibility Randomized Controlled Trial

doi:10.2196/33776

Published on 21.1.2022 in Vol 11, No 1 (2022): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33776, first published September 22, 2021.

$Effectiveness of Mindfulness-Based Cognitive Therapy With Follow-Up Sessions for Pharmacotherapy-Refractory Anxiety Disorders: Protocol for a Feasibility Randomized Controlled Trial$

Effectiveness of Mindfulness-Based Cognitive Therapy With Follow-Up Sessions for Pharmacotherapy-Refractory Anxiety Disorders: Protocol for a Feasibility Randomized Controlled Trial

Mitsuhiro Sado^{1, 2}

; Akira Ninomiya^{1, 2}

; Maki Nagaoka^{1, 2}

; Akihiro Koreki^{1, 2, 3}

; Naho Goto^{1, 2}

; Yohei Sasaki¹

; Chie Takamori¹

; Teppei Kosugi¹

; Masashi Yamada^{1, 2}

; Sunre Park⁴

; Yasunori Sato^{5, 6}

; Daisuke Fujisawa^{1, 7}

; Atsuo Nakagawa^{1, 5}

; Masaru Mimura^{1, 2}

Article Authors Cited by (1) Tweetations (4) Metrics

Journals

Dizaj Khalili M, Makvand Hosseini S, Sabahi P. Effects of Mindfulness-Based Cognitive Therapy on Anxiety Sensitivity in Patients with Multiple Sclerosis. Jundishapur Journal of Chronic Disease Care 2023;12(1) View

This paper is in the following e-collection/theme issue:

Effectiveness of Mindfulness-Based Cognitive Therapy With Follow-Up Sessions for Pharmacotherapy-Refractory Anxiety Disorders: Protocol for a Feasibility Randomized Controlled Trial

Effectiveness of Mindfulness-Based Cognitive Therapy With Follow-Up Sessions for Pharmacotherapy-Refractory Anxiety Disorders: Protocol for a Feasibility Randomized Controlled Trial

Journals